Screener
Tyra Biosciences, Inc. TYRA Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Tyra Biosciences, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
FAQ
- What is Tyra Biosciences, Inc.'s debt-to-equity?
- Tyra Biosciences, Inc. (TYRA) reported debt-to-equity of 0× in Q1 2026.
- How has Tyra Biosciences, Inc.'s debt-to-equity changed year-over-year?
- Tyra Biosciences, Inc.'s debt-to-equity decreased by 22.2% year-over-year, from 0× to 0×.
- What is the long-term trend for Tyra Biosciences, Inc.'s debt-to-equity?
- Over 4 years (2021 to 2025), Tyra Biosciences, Inc.'s debt-to-equity has grown at a 54.8% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Tyra Biosciences, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude